Keyphrases
Left Ventricular Noncompaction
100%
Japan
78%
Type 2 Diabetes Mellitus (T2DM)
69%
Hepatocellular Carcinoma
61%
Kawasaki Disease
56%
Japanese Population
53%
3T3-L1 Adipocytes
39%
Single nucleotide Polymorphism
35%
Liver
35%
Lung Cancer
35%
Tumor
33%
Insulin
31%
Confidence Interval
28%
Insulin Receptor Substrate 1 (IRS1)
27%
Advanced Gastric Cancer
26%
Chemotherapy
26%
Major Depressive Disorder
26%
Elderly Patients
24%
Liver Disease
24%
Insulin Resistance
24%
Interleukin-1β
23%
Replication Study
23%
Basic Fibroblast Growth Factor (bFGF)
22%
Tumor Necrosis Factor-α
22%
Meta-analysis
22%
Near-infrared Spectroscopy
21%
Insulin Receptor
21%
Overexpression
21%
Advanced Hepatocellular Carcinoma
21%
Congenital Heart Disease
21%
Insulin Signaling
20%
Older Men
20%
Hypertrophic Cardiomyopathy
20%
Systematic Meta-analysis
19%
Stomach
19%
Sorafenib
19%
Serum Levels
19%
Cisplatin
19%
Non-small Cell Lung Cancer (NSCLC)
18%
Attention Deficit Hyperactivity Disorder
18%
Genome-wide Association Study
18%
Japanese children
17%
Clinical Significance
17%
Monotherapy
17%
Cardiomyopathy
17%
Heart Failure
17%
Odds Ratio
16%
Next-generation Sequencing
16%
Chronic Hepatitis C
16%
5-fluorouracil (5-FU)
16%
Hepatocyte Growth Factor
16%
Liver Injury
16%
Advanced Cirrhosis
16%
Pediatric Patients
16%
Dilated Cardiomyopathy
15%
Docetaxel
15%
Overall Survival
15%
Prognostic Factors
15%
Progression-free Survival
15%
Warfarin
14%
Hepatitis C Virus
14%
Sirtuin 1 (SIRT1)
14%
Autopsy
14%
Older Women
14%
Lipopolysaccharide
14%
Coagulation
14%
Pioglitazone
14%
Nivolumab
14%
Ultrasound Examination
14%
Computed Tomography
13%
Gastric Cancer
13%
Healthy Controls
13%
T Cells
13%
Phosphoinositide 3-kinase (PI3K)
13%
Clinical Trials
13%
Rectum
13%
Differential Diagnosis
12%
Bipolar Disorder
12%
Young Males
12%
Clinical Characteristics
12%
Asthma
12%
Fibroblasts
12%
Mouse Model
12%
Type 2 Diabetic Patients
12%
Genetic Variants
11%
Body Mass Index
11%
Depression Severity
11%
Fetus
11%
Gene Variants
11%
B Cells
11%
Comorbidity
11%
Multi-channel
11%
Retrospective Cohort Study
11%
Patients with Schizophrenia
11%
Median Progression-free Survival
11%
Hemodynamic Response
11%
Interleukin-6
11%
Schizophrenia
11%
Dyspnea
11%
Proton Pump Inhibitors
11%
Medicine and Dentistry
Noncompaction Cardiomyopathy
84%
Hepatocellular Carcinoma
64%
Neoplasm
54%
Maturity Onset Diabetes of the Young
33%
Lung Cancer
33%
Abdominal Cancer
31%
Congestive Heart Failure
30%
Disease
29%
Chemotherapy
27%
Persistent Truncus Arteriosus
27%
Liver Cirrhosis
26%
Retrospective Study
22%
Liver Disease
22%
Myocardial Disease
22%
Drug Therapy
20%
Elderly Patient
19%
Computer Assisted Tomography
19%
Overall Survival
19%
Carcinoma
18%
Recurrent Disease
18%
Small Cell Lung Cancer
18%
Messenger RNA
18%
Lymphocyte
17%
Adolescence
17%
Radiofrequency Ablation
16%
Outpatient
16%
Patient with Kawasaki Disease
16%
Adverse Event
15%
Amino Terminal Sequence
14%
Liver Injury
14%
Single Nucleotide Polymorphism
14%
Diagnosis
14%
Next Generation Sequencing
14%
Nivolumab
14%
Liver Metastasis
14%
Liver Tumor
13%
Heart Single Ventricle
13%
Retrospective Cohort Study
13%
Multidrug Resistance
12%
Arm
12%
Chronic Hepatitis C
12%
Progression Free Survival
12%
Lung
12%
Nonalcoholic Fatty Liver
12%
Attention Deficit Disorder
12%
Pediatrics
12%
MYH7
12%
Cisplatin
11%
Coronary Artery
11%
Dilated Cardiomyopathy
11%
Systematic Review
11%
Magnetic Resonance Imaging
11%
In Vitro
11%
Primary Biliary Cirrhosis
11%
Hepatocellular Carcinoma Cell Line
11%
Hepatoma Cell
11%
Neutrophil
11%
Corticotropin
11%
Multidrug Resistance Associated Protein 1
11%
Pleura Effusion
11%
Lymphoma Cell
11%
Programmed Cell Death
11%
Non Small Cell Lung Cancer
11%
Sirtuin1
11%
Liver Graft
11%
Point-of-Care Ultrasound
11%
Comorbidity
11%
Dyspnea
11%
Genome Wide Association Study
11%
Liver Fibrosis
11%
Immunoglobulin
11%
Asthma
10%
Pediatrics Patient
10%
Odds Ratio
10%
Ascites
10%
Lung Adenocarcinoma
9%
Differential Diagnosis
9%
Hepatitis C Virus
9%
Diaphragm
9%
Quality of Life
9%
Sarcomere
9%
Hepatic Encephalopathy
9%
Brain Natriuretic Peptide
9%
Hypertrophic Cardiomyopathy
9%
Apoplexy
9%
Pancreas Cancer
9%
Pregnancy
9%
Metastatic Carcinoma
9%
Biopsy Technique
9%
Electrocardiogram
9%
Monotherapy
9%
Immunohistochemistry
9%
Liver Dysfunction
9%
Epidermal Growth Factor Receptor
8%
Prognostic Factor
8%
Echocardiography
8%
Sorafenib
8%
Cell Line
8%
Antithrombin III
8%
Hematoma
8%